186 related articles for article (PubMed ID: 8640758)
1. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma.
Ermak G; Jennings T; Robinson L; Ross JS; Figge J
Cancer Res; 1996 Mar; 56(5):1037-42. PubMed ID: 8640758
[TBL] [Abstract][Full Text] [Related]
2. Deregulated alternative splicing of CD44 messenger RNA transcripts in neoplastic and nonneoplastic lesions of the human thyroid.
Ermak G; Gerasimov G; Troshina K; Jennings T; Robinson L; Ross JS; Figge J
Cancer Res; 1995 Oct; 55(20):4594-8. PubMed ID: 7553635
[TBL] [Abstract][Full Text] [Related]
3. Novel CD44 messenger RNA isoforms in human thyroid and breast tissues feature unusual sequence rearrangements.
Ermak G; Jennings T; Boguniewicz A; Figge J
Clin Cancer Res; 1996 Aug; 2(8):1251-4. PubMed ID: 9816294
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms regulating the tumor-targeting potential of splice-activated gene expression.
Hayes GM; Dougherty ST; Davis PD; Dougherty GJ
Cancer Gene Ther; 2004 Dec; 11(12):797-807. PubMed ID: 15359288
[TBL] [Abstract][Full Text] [Related]
5. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells.
Kryworuckho M; Diaz-Mitoma F; Kumar A
Immunology; 1995 Sep; 86(1):41-8. PubMed ID: 7590880
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium.
Woerner SM; Givehchian M; Dürst M; Schneider A; Costa S; Melsheimer P; Lacroix J; Zöller M; Doeberitz MK
Clin Cancer Res; 1995 Oct; 1(10):1125-32. PubMed ID: 9815903
[TBL] [Abstract][Full Text] [Related]
7. Intronic UGG repeats coordinate splicing of CD44 alternative exons v8 and v9.
Galiana-Arnoux D; Del Gatto-Konczak F; Gesnel MC; Breathnach R
Biochem Biophys Res Commun; 2005 Oct; 336(2):667-73. PubMed ID: 16137657
[TBL] [Abstract][Full Text] [Related]
8. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.
Fox SB; Fawcett J; Jackson DG; Collins I; Gatter KC; Harris AL; Gearing A; Simmons DL
Cancer Res; 1994 Aug; 54(16):4539-46. PubMed ID: 7519124
[TBL] [Abstract][Full Text] [Related]
9. Transient expression of CD44 variant isoforms in the ontogeny of the rat: ectoderm-, endoderm- and mesoderm-derived cells express different exon combinations.
Weber B; Rösel M; Arch R; Möller P; Zöller M
Differentiation; 1996 Mar; 60(1):17-29. PubMed ID: 8935925
[TBL] [Abstract][Full Text] [Related]
10. Alternative splicing as a novel of means of regulating the expression of therapeutic genes.
Hayes GM; Carpenito C; Davis PD; Dougherty ST; Dirks JF; Dougherty GJ
Cancer Gene Ther; 2002 Feb; 9(2):133-41. PubMed ID: 11857030
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of CD44 variants 6 and 7 in human endometrial cancer.
Katsura M; Furumoto H; Nishimura M; Kamada M; Aono T
Gynecol Oncol; 1998 Nov; 71(2):185-9. PubMed ID: 9826458
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD44 and variant isoforms in cultured human retinal pigment epithelial cells.
Liu NP; Roberts WL; Hale LP; Levesque MC; Patel DD; Lu CL; Jaffe GJ
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2027-37. PubMed ID: 9331266
[TBL] [Abstract][Full Text] [Related]
13. Complex CD44 splicing combinations in synovial fibroblasts from arthritic joints.
Croft DR; Dall P; Davies D; Jackson DG; McIntyre P; Kramer IM
Eur J Immunol; 1997 Jul; 27(7):1680-4. PubMed ID: 9247577
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD44 splice variants in normal respiratory epithelium and bronchial carcinomas: no evidence for altered CD44 splicing in metastasis.
Givehchian M; Woerner SM; Lacroix J; Zöller M; Drings P; Becker H; Kayser K; Ridder R; von Knebel Doeberitz M
Oncogene; 1996 Mar; 12(5):1137-44. PubMed ID: 8649806
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer overexpresses CD44 variants 7-9 at the messenger RNA and protein level.
Iczkowski KA; Bai S; Pantazis CG
Anticancer Res; 2003; 23(4):3129-40. PubMed ID: 12926045
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD44 variant isoforms in malignant melanoma.
Seiter S; Schadendorf D; Herrmann K; Schneider M; Rösel M; Arch R; Tilgen W; Zöller M
Clin Cancer Res; 1996 Mar; 2(3):447-56. PubMed ID: 9816190
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck.
Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M
J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348
[TBL] [Abstract][Full Text] [Related]
18. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
[TBL] [Abstract][Full Text] [Related]
19. INSL-3 is expressed in human hyperplastic and neoplastic thyrocytes.
Hombach-Klonisch S; Hoang-Vu C; Kehlen A; Hinze R; Holzhausen HJ; Weber E; Fischer B; Dralle H; Klonisch T
Int J Oncol; 2003 May; 22(5):993-1001. PubMed ID: 12684664
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines.
Stickeler E; Runnebaum IB; Möbus VJ; Kieback DG; Kreienberg R
Anticancer Res; 1997; 17(3C):1871-6. PubMed ID: 9216637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
